Schizophrenia as one extreme of a sexually selected fitness indicator

Schizophrenia Research
Andrew ShanerJim Mintz

Abstract

Schizophrenia remains an evolutionary paradox. Its delusions, hallucinations and other symptoms begin in adolescence or early adulthood and so devastate sexual relationships and reproductive success that selection should have eliminated the disorder long ago. Yet it persists as a moderately heritable disorder at a global 1% prevalence--too high for new mutations at a few genetic loci. We suggest that schizophrenia persists and involves many loci because it is the unattractive, low-fitness extreme of a highly variable mental trait that evolved as a fitness ("good genes") indicator through mutual mate choice. Here we show that this hypothesis explains many key features of schizophrenia and predicts that some families carry modifier alleles that increase the indicator's neurodevelopmental sensitivity to heritable fitness and condition. Such alleles increase the extent to which high-fitness family members develop impressive courtship abilities and achieve high reproductive success, but also increase the extent to which low-fitness family members develop schizophrenia. Here we introduce this fitness indicator model of schizophrenia, discuss its explanatory power, explain how it resolves the evolutionary paradox, discuss its implicat...Continue Reading

References

Mar 21, 1970·Nature·W H James
Apr 1, 1971·The British Journal of Psychiatry : the Journal of Mental Science·M Carter, C A Watts
Jan 1, 1982·Archiv für Psychiatrie und Nervenkrankheiten·F HaverkampT Hilger
Sep 1, 1995·Journal of Comparative Physiology. A, Sensory, Neural, and Behavioral Physiology·D E Wood
Jan 1, 1995·Neuroscience and Biobehavioral Reviews·M R Melis, A Argiolas
Mar 17, 1994·Nature·D I PerrettS Yoshikawa
Jan 1, 1993·Schizophrenia Bulletin·K S Kendler, S R Diehl
Jun 1, 1993·Acta Psychiatrica Scandinavica·S Nanko, J Moridaira
Jan 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·H HäfnerA Riecher-Rössler
Mar 21, 1998·Schizophrenia Bulletin·H HäfnerA Stein
Apr 29, 1998·Schizophrenia Research·T J Crow
Apr 29, 1998·Schizophrenia Research·P L Randall
Apr 10, 1999·Journal of Neurogenetics·W S Neckameyer
Jul 3, 1999·Nature·I S Penton-VoakR Minamisawa
Aug 31, 1999·Journal of Abnormal Psychology·J C Wakefield
Dec 1, 1999·Harvard Review of Psychiatry·M T TsuangS V Faraone
Jun 30, 2000·The American Journal of Psychiatry·H E Hulshoff PolR S Kahn
Oct 21, 2000·The British Journal of Psychiatry : the Journal of Mental Science·S BrownB Barraclough
Jan 12, 2001·European Archives of Psychiatry and Clinical Neuroscience·A Jablensky
Mar 30, 2001·Schizophrenia Research·M AvilaH Adami
Apr 5, 2001·Nature·J S KotiahoJ L Tomkins
Apr 24, 2001·The British Journal of Psychiatry. Supplement·M T TsuangS V Faraone
Jun 29, 2001·Archives of General Psychiatry·D LichtermannJ Lönnqvist
Jun 19, 2001·American Journal of Human Genetics·J K Pritchard
Dec 26, 2001·Archives of General Psychiatry·S L BukaR H Yolken
Jan 12, 2002·Archives of General Psychiatry·Tyrone D CannonCarl-Gustav Standertskjöld-Nordenstam
Jan 15, 2002·Proceedings. Biological Sciences·David Houle, Alexey S Kondrashov
Apr 18, 2002·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Hanna Kokko, Rufus A Johnstone
Jun 6, 2002·Schizophrenia Bulletin·Faith B DickersonFrederick Parente
Jul 26, 2002·Proceedings. Biological Sciences·Wolfgang ForstmeierBernd Leisler
Apr 10, 2003·The Psychiatric Clinics of North America·Colm McDonald, Kieran C Murphy
May 29, 2003·Proceedings. Biological Sciences·Hanna KokkoJosephine Morley
Jun 5, 2003·Evolution; International Journal of Organic Evolution·László Zsolt GaramszegiJohannes Erritzøe
Oct 17, 1964·Nature·J HUXLEYA HOFFER
Jan 1, 1996·Journal of Psychopharmacology·C Frith

❮ Previous
Next ❯

Citations

Apr 5, 2012·The British Journal of Psychiatry : the Journal of Mental Science·George Kirov, Geoffrey Miller
Mar 16, 2006·Proceedings. Biological Sciences·Daniel Nettle, Helen Clegg
Sep 6, 2007·Proceedings. Biological Sciences·Bernard CrespiSteve Dorus
Nov 24, 2007·Schizophrenia Bulletin·Godfrey D Pearlson, Bradley S Folley
Jan 29, 2013·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jenny van Dongen, Dorret I Boomsma
Aug 21, 2015·PeerJ·Tobias Göllner, Martin Fieder
May 13, 2017·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Marco Del Giudice
Mar 1, 2006·Human Nature : an Interdisciplinary Biosocial Perspective·Martie G Haselton, Geoffrey F Miller
Feb 11, 2020·Annual Review of Clinical Psychology·Tiffany A Greenwood
Dec 1, 2008·Human Nature : an Interdisciplinary Biosocial Perspective·Andrew ShanerJim Mintz
Aug 11, 2020·Human Genetics·Gerard MuntanéElisabet Vilella
Oct 23, 2020·General Psychiatry·Wen Han, Bin-Bin Chen
Apr 24, 2021·Attachment & Human Development·John D HaltiganSoha Khorsand
Aug 10, 2021·Development and Psychopathology·Marco Del Giudice, John D Haltigan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.